Please assess the completion status of the following clinical trial:

Trial Title: Ibuprofen Lozenge in Acute Sore Throat Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male or female aged at least 18 years old~* patient with an acute sore throat~Exclusion Criteria:~* Severe respiratory tract infection (pneumonia, bronchitis or laryngitis)~* Oro-pharyngeal paresthesia or mycosis~* Severely traumatised and/or very severe oromucosal inflammation~* Tonsillopharyngectomy~* Peritonsillar abscess~* Hypersensitivity to ibuprofen or other NonSteroidal Anti-Inflammatory Drugs (NSAIDs) (including bronchospasm) or to excipients~* Long term use (≥ 3 times per week within the last month or regular intake within the last 3 months before randomisation) of antiinflammatory drugs- Any long-acting or slow release analgesic intake including NonSteroidal Anti-Inflammatory Drugs (NSAIDs)within 24 hours before randomisation (e.g. piroxicam or naproxen)~* Any anti-inflammatory drugs intake by systemic route within 12 hours before randomisation~* Any paracetamol intake within 6 hours before randomisation~* Any cold medication (decongestant, antihistamine, expectorant, antitussive) within 6 hours before randomisation~* Any topical throat medication intake containing or not a local oral anaesthetic such as lozenge, spray, mouth rinse within 4 hours before randomisation~* Heavy smokers (\>20 cigarettes/day)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Drug (Type: EXPERIMENTAL): V0498, Ibuprofen 25 mg
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).